Hem › Levercancer (hepatocellulärt karcinom) › Maryland › Baltimore
Kliniska studier för Levercancer (hepatocellulärt karcinom) i Baltimore, MD
11 studier för Levercancer (hepatocellulärt karcinom) söker deltagare vid platser i och runt Baltimore (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RekryterarFas 1
- Exelixis Clinical Site #14, Baltimore
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
RekryterarFas 1/2
- Research Facility, Baltimore
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
RekryterarFas 1
- John Hopkins University, Baltimore
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
RekryterarObservationsstudie
- Johns Hopkins Hospital, Baltimore
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekryterarFas 1/2
- Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center, Baltimore
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
RekryterarFas 1/2
- Research Site, Baltimore
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RekryterarFas 2
- The John Hopkins Hospital, Baltimore
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Rekryterar
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
RekryterarFas 1/2
- The Sidney Kimmel Comprehensive Cancer Center, Baltimore
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
RekryterarFas 2
- University of Maryland Medical Center, Baltimore
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekryterarObservationsstudie
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Towson · 8 mi bort
Levercancer (hepatocellulärt karcinom)-studier i andra städer
- Houston, TX31 studier
- New York City, NY24 studier
- Dallas, TX19 studier
- Los Angeles, CA19 studier
- Boston, MA18 studier
- Cleveland, OH18 studier
- Chicago, IL16 studier
- Philadelphia, PA16 studier
- Pittsburgh, PA15 studier
- San Francisco, CA14 studier
- Orange, CA14 studier
- Jacksonville, FL14 studier
Andra studier i Baltimore
- Icke-småcellig lungcancer60 studier
- Bröstcancer47 studier
- Prostatacancer43 studier
- Lungcancer40 studier
- Cancer (alla typer)37 studier
- Bukspottkörtelcancer31 studier
- Kolorektal cancer31 studier
- Metastaserande cancer28 studier
- Övervikt26 studier
- Blåscancer24 studier
- Hjärtsvikt24 studier
- Äggstockscancer22 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.